Do We Really TRUST Radical Surgery in Advanced Ovarian Cancer?

ESGO eAcademy, Faculty / Presenters, 4193887

Sentine node positive POLE-mutated endometrial cancer

ESGO eAcademy, Giorgio Bogani, 4193756

Panel Discussion and Live Audience Q&A

ESGO eAcademy, Faculty / Presenters, 4193755

Case Study Two: Stage IVB High-Grade p53 WT (pMMR, POLE & ER negative) Serous Endometrial Cancer

ESGO eAcademy, Els Van Nieuwenhuysen, 4193754

Panel Discussion and Live Audience Q&A

ESGO eAcademy, Faculty / Presenters, 4193753

Hall D2 28-feb

ESGO eAcademy, Faculty / Presenters, 4193383

Case Study One: Stage IIIC2 High-Grade p53 mut (POLE wt, pMMR) Endometrial Carcinoma

ESGO eAcademy, Stephan Polterauer, 4193752

Navigating the Complexity of Treatment of First-Line, Advanced/Recurrent Endometrial Cancer

ESGO eAcademy, Domenica Lorusso, 4193751

Endometrial Cancer Through the Clinical Lens: From Diagnosis to Decision

ESGO eAcademy, Faculty / Presenters, 4193884

Welcome and Introductions

ESGO eAcademy, Domenica Lorusso, 4193750

Presidential Lecture

ESGO eAcademy, Anna Fagotti, 4193748

Laudation Speech for ESGO President

ESGO eAcademy, Claudia Marchetti, 4193746

Laudation Speech for ESGO President

ESGO eAcademy, Nicolo Bizzarri, 4193747

Laudation Speech for ESGO President

ESGO eAcademy, Francesco Fanfani, 4193745

ESGO Giovanni Scambia Award for Exceptional Mentorship

ESGO eAcademy, Pedro Ramirez, 4193744

ESGO Giovanni Scambia Award for Exceptional Mentorship

ESGO eAcademy, Aleksandra Strojna, 4193743

ESGO Helga Salvesen Translational Research Award

ESGO eAcademy, Frederic Amant, 4193742

ESGO Helga Salvesen Translational Research Award

ESGO eAcademy, Maja Pakiz, 4193741

Presidential and Awards Session

ESGO eAcademy, Faculty / Presenters, 4193882

AUD 10-11-12 28-feb

ESGO eAcademy, Faculty / Presenters, 4193386

Discussion

ESGO eAcademy, Faculty / Presenters, 4193740

Patients’ Voices Are Shaping the System: From Tokenism to Co-Creation

ESGO eAcademy, Ico Toth, 4193739

Laparoscopic resection of a presacral pelvic schwannoma presenting with pain and neurological symptoms

ESGO eAcademy, Özgün Ceylan, 4193723

Key pelvic nerve anatomy regarding low anterior resection syndrome: A surgical demonstration for nerve preservation in pelvic surgery

ESGO eAcademy, Victor Lago, 4193722

Cancer Care Plan; Post-Op Treatment Advanced Stage & Oligoprogressive Disease; Recurrent Disease; Palliative Treatment/Best Supportive Care

ESGO eAcademy, Faculty / Presenter(s), 4193729

Single-port robotic orthotopic ovarian tissue autotransplantation: A step-by-step case report

ESGO eAcademy, Valentina Bruno, 4193721

Holistic Recovery: The New Standard of Success in Gynaecologic Oncology

ESGO eAcademy, Kathrin Kirchheiner, 4193738

Lighting the way: indocyanine green-guided laparoscopic transabdominal cerclage in pregnancy after fertility-sparing treatment for cervical cancer.

ESGO eAcademy, Nicola Macellari, 4193720

Introduction and General Recommendations

ESGO eAcademy, Ane Gerda Z Eriksson, 4193724

Robotic-assisted uterine transposition for fertility preservation in patients treated with radiotherapy for pelvic malignancies: from transposition to repositioning.

ESGO eAcademy, Chiara Innocenzi, 4193719

Quality of Life at the Forefront: Redefining Research and Regulation

ESGO eAcademy, Nadeem R. Abu-Rustum, 4193737

Beyond Survival: Redefining Success Through Quality of Life in Gynaecological Oncology (organised by ENGAGe)

ESGO eAcademy, Faculty / Presenters, 4193881

New ESGO Ovarian Cancer Guidelines: Practical Applications through Tumour Board Simulation and Updated Care Algorithms - part II

ESGO eAcademy, Faculty / Presenters, 4193880

Video Session 3: Miscellaneous

ESGO eAcademy, Faculty / Presenters, 4193879

Exploratory laparoscopy for tubo-ovarian malignancy.

ESGO eAcademy, Witold Gertych, 4193717

Integrating Palliative Care and Maintenance Therapy: Supporting Patients beyond Curative Treatment

ESGO eAcademy, Vesna Kesic, 4193711

Laparoscopic management of bulky para-aortic nodal disease in primary ovarian cancer: A ten step video demonstration

ESGO eAcademy, Matteo Loverro, 4193716

Discussant

ESGO eAcademy, Antonio Gonzalez Martin, 4193707

Shared Decision-Making in Gynaecological Oncology: Enhancing Patient-Physician Collaboration

ESGO eAcademy, Annemijn Aarts, 4193710

TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT ov33 / AGO-OVAR OP7)

ESGO eAcademy, Berit Jul Mosgaard, 4193706

Robotic approach to secondary cytoreduction with distal gastrosplenopancreatectomy in recurrent high-grade serous ovarian cancer

ESGO eAcademy, SILVIO ANDREA RUSSO, 4193715

Laparoscopic assessment of resectability in ovarian cancer: A 10-step standardized approach.

ESGO eAcademy, Charlotte Chabert, 4193714

Impact of HIPEC on survival and morbidity after interval debulking surgery (R0) in ECOG 0-1 patients with advanced ovarian cancer: analysis of the international SUROVA study

ESGO eAcademy, Nabil Manzour, 4193705

Managing Patients at Risk or with Preinvasive Gynaecological Lesions: Navigating the Challenges of Long-Term Follow-Up and Diagnostic Uncertainty

ESGO eAcademy, Houssein El Hajj, 4193709

Approach to the hepato-gastric region in ovarian cancer

ESGO eAcademy, Giulio Ricotta, 4193713

ICON8B:GCIG phase III evaluation of first-line weekly dose-dense chemotherapy and bevacizumab in high-risk stage III-IV ovarian cancer. Final Overall Survival (OS) and exploratory analysis by KELIM chemosensitivity/ interval surgical cytoreduction.

ESGO eAcademy, Andrew Clamp, 4193703

The Applications of Dynamic Cell Imaging in Ovarian Cancer

ESGO eAcademy, Nicolo Bizzarri, 4193712

Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: final analysis results from the randomized double-blind phase 3 ENGOT-ov65/KEYNOTE-B96 study

ESGO eAcademy, Nicoletta Colombo, 4193702

Optimising the Patient-Physician Communication in a Shared Decision and Integrative Patient Care (organised by ENGAGe)

ESGO eAcademy, Faculty / Presenters, 4193877

Video Session 2: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193878

Best Oral Session 2: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193876

The Patient Journey in Gynaecological Oncology: From Prevention to Diagnosis, Treatment, and Palliative Care

ESGO eAcademy, Kim Hulscher, 4193708

Mocertatug rezetecan, a B7-H4-targeted antibody-drug conjugate, in combination with bevacizumab in patients with platinum-sensitive ovarian cancer: results from a phase 1 study

ESGO eAcademy, Changyu Wang, 4193697

Discussion

ESGO eAcademy, Faculty / Presenters, 4193701

Discussion

ESGO eAcademy, Faculty / Presenters, 4193689

Efficacy, safety, and quality of life in patients aged =75 years in MIRASOL (GOG 3045/ENGOT-ov55): mirvetuximab soravtansine vs investigator’s choice chemotherapy in folate receptor alpha-positive platinum-resistant ovarian cancer

ESGO eAcademy, Annamaria Ferrero, 4193696

RANDOMIZED PHASE II STUDY OF P62/SQSTM1-ENCODING PLASMID (ELENAGEN) IN COMBINATION WITH GEMCITABINE FOR PLATINUM-RESISTANT OVARIAN CANCER

ESGO eAcademy, Gabriel Levin, 4193695

The Role of Immunotherapy in Cervical Cancer

ESGO eAcademy, Domenica Lorusso, 4193688

Induction Therapy for Locally Advanced Disease

ESGO eAcademy, Nicoletta Colombo, 4193687

RECOVER (recurrence ovarian cancer real life): A MITO (multicenter italian trials in ovarian cancer) real-world study comparing cytoreductive surgery and chemotherapy in platinum-sensitive recurrent ovarian cancer with known BRCA status

ESGO eAcademy, Alice Zampolini Faustini, 4193694

Chemoradiation for Locally Advanced Disease

ESGO eAcademy, Primoz Petric, 4193686

From Data to Decisions: AI Empowering Surgical Decision-Making and Image Guided Surgery

ESGO eAcademy, Andrea Rosati, 4193698

Management of Early-Stage Disease

ESGO eAcademy, Ignacio Zapardiel, 4193685

Identification of patients with advanced ovarian cancer (AOC) and high risk for morbidity and mortality undergoing primary therapy in a specialized ESGO certificated tertiary cancer center.

ESGO eAcademy, Malak Moubarak, 4193692

Preventable Disease - Vaccination Programmes

ESGO eAcademy, Murat Gultekin, 4193684

SUROVA predictive score for postoperative complications after primary cytoreductive surgery in advanced ovarian cancer

ESGO eAcademy, Enrique Chacon, 4193691

Patient Story

ESGO eAcademy, Anne de Middelaer, 4193683

Cancer risk associated with hormonal contraceptive use in BRCA1/2 pathogenic variant carriers: A big data study

ESGO eAcademy, Chen Nahshon, 4193690

Potential of AI in Theatre

ESGO eAcademy, Faculty / Presenters, 4193875

Mini Oral Session 3: Ovarian Cancer

ESGO eAcademy, Faculty / Presenters, 4193874

Grand Rounds 4: Cervical Cancer

ESGO eAcademy, Faculty / Presenters, 4193873

Introduction

ESGO eAcademy, Ignacio Zapardiel, 4193682

Boosting the OR: AI-Driven Efficiency and Surgical Performance

ESGO eAcademy, Alexander Shushkevich, 4193699

Discussion

ESGO eAcademy, Faculty / Presenters, 4193668

Beyond ADC? Which Drugs in the Future for Ovarian Cancers Patients?

ESGO eAcademy, Ilaria Colombo, 4193667

How to Manage ADC in Clinical Practice: From Safety to Sequence

ESGO eAcademy, Frederik Marmé, 4193666

What Are the Most Promising ADC for Gynaecological Cancer?

ESGO eAcademy, Isabelle Ray-Coquard, 4193665

Evolving Strategies in Platinum-Resistant Ovarian Cancer: Bridging Evidence, Regulation, and Clinical Care

ESGO eAcademy, Faculty / Presenters, 4193871

The Future of Ovarian Cancer: ADC and Beyond

ESGO eAcademy, Faculty / Presenters, 4193870

Improving endometrial cancer assessment by combining the new technique of genomic profiling with surgical extra uterine disease assessment (EUGENIE).

ESGO eAcademy, Rita Trozzi, 4193657

CLINICAL ACTIVITY OF ACR-368 IN PATIENTS WITH ENDOMETRIAL CARCINOMA PROSPECTIVLY SELECTED BY ONCOSIGNATURE - A PHASE 2 STUDY - ACR-368-201/GOG3082 (NCT05548296

ESGO eAcademy, Panagiotis Konstantinopoulos, 4193656

Levonorgestrel-releasing intrauterine device alone for managing early-stage endometrial cancer and endometrial hyperplasia with atypia in patients unfit for surgery: the endoiud study.

ESGO eAcademy, Martina Arcieri, 4193655

The Most Relevant Trials that Have Changed Our Disease Management in Cervical Cancer

ESGO eAcademy, Ilaria Colombo, 4193660

Efficacy and safety of immune checkpoint inhibitors in clear cell ovarian cancer: A systematic review and meta-analysis of phase II clinical trials

ESGO eAcademy, Mariana Noronha, 4193654

Discussion

ESGO eAcademy, Faculty / Presenters, 4193645

What defines infiltrative invasion as a poor prognostic factor in primary mucinous ovarian cancer? - A multicentre retrospective cohort

ESGO eAcademy, Tejumola Olaoye, 4193653

Novel Agents in the Pipeline

ESGO eAcademy, Viola Heinzelmann, 4193644

Temporal heterogeneity in antibody-drug conjugate targets in paired primary and recurrent ovarian cancer samples

ESGO eAcademy, Hualei Bu, 4193652

The impact of clinical sample collection timing on FRa expression and mirvetuximab soravtansine patient outcomes in the MIRASOL (GOG 3045/ENGOT-ov55) trial

ESGO eAcademy, Sabrina Chiara Cecere, 4193651

Chemoradiation for Locally Advanced Disease

ESGO eAcademy, Cyrus Chargari, 4193643

The Most Relevant Trials that Have Changed Our Disease Management in Endometrial Cancer

ESGO eAcademy, Domenica Lorusso, 4193659

Results from the first-in-human phase 1 study of LY4170156, a folate receptor alpha-targeting antibody drug conjugate, in ovarian cancer patients previously exposed to antibody drug conjugate therapy

ESGO eAcademy, Ainhoa Madariaga, 4193650

Neoadjuvant chemotherapy with interval debulking surgery in elderly women with advanced ovarian, fallopian tube, or primary peritoneal cancer: real-world evidence from japan

ESGO eAcademy, Hiroko Machida, 4193649

Management of Early-Stage Disease

ESGO eAcademy, Sven Mahner, 4193642

AI-driven prediction of ovarian cancer biology from diagnostic laparoscopy: preliminary results of the PANTHER-AI project

ESGO eAcademy, Alice Zampolini Faustini, 4193648

Development in Sentinel Node Procedure

ESGO eAcademy, Maaike Oonk, 4193641

Mind the gap: emergency admissions and survival inequities in ovarian cancer: a national population-based study using routinely collected data in england.

ESGO eAcademy, Georgia Zachou, 4193647

Patient Story

ESGO eAcademy, Carmen van Wamelen, 4193640

Transforming ovarian cancer diagnostic pathways (SONATA): ROMA versus CA125 in community setting for diagnosis of ovarian and uterine cancer, real-world prospective diagnostic test accuracy study: preliminary analysis of secondary outcome

ESGO eAcademy, Sudha Sundar, 4193646

Introduction

ESGO eAcademy, Sven Mahner, 4193639